TAK-243 Uses, Dosage, Side Effects and more
TAK-243 is under investigation in clinical trial NCT03816319 (TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia).
| Trade Name | TAK-243 |
| Generic | TAK-243 |
| Type | |
| Formula | C19H20F3N5O5S2 |
| Weight | Average: 519.51 Monoisotopic: 519.085795601 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
